More recently established treatments for RVO have taken a giant leap forward from laser photocoagulation since intravitreally ...

The results of a phase 1b study that evaluated a potential new treatment for macular edema associated with inflammation, ...

In both studies, Vabysmo was found to be noninferior to aflibercept, with average vision gains being comparable between the treatment groups. The Food and Drug Administration (FDA) has approved ...

Switzerland-based generic and biosimilar drugs specialist Sandoz today announced that the US Food and Drug Administration ...

The optic cup and macula of a 24-year-old female. Image is released to Wikimedia commons with patient consent. Imaged with a non-mydriatic fundus camera at Pacific University College of Optometry.

Resistant diabetic macular edema may necessitate transitioning from one intravitreal pharmacotherapy to another when the edema is persistent — a practice sometimes undertaken in clinical management.

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Brolucizumab ...

TORONTO, Ontario — The use of a topical ocular nonsteroidal anti-inflammatory drug (NSAID) before and after cataract surgery leads to meaningful reductions in postoperative macular edema in patients ...

In a statement, EyePoint CEO Jay Duker, M.D., lauded Campbell’s “proven track record of successfully launching innovative ...

Seasoned commercial executive with over 30 years of leadership in retinal disease across biotech and large pharma –– Brings established track ...

Spot early warning signs of macular degeneration before vision loss begins. Know symptoms, risk factors, and when to see an ...